These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19335742)

  • 1. Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension.
    Pulido T; Sandoval J; Roquet I; Gutiérrez R; Rueda T; Peña H; Santos E; Miranda MT; Lupi E
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():14-8. PubMed ID: 19335742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study.
    Bijkerk S; Lourens HJ; Mares WGN; van Kampen CA; van der Veen MJ; Adriaansen HJ; Ponfoort ED; Festen B; Westendorp GW; Rovers JMP; Groot GMC; Bootsma HR; Amelung LM; Bins S; Velders G; Bemelmans RHH
    J Thromb Haemost; 2024 Jul; 22(7):1847-1856. PubMed ID: 38580096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (Thelin®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension.
    Owen K; Cross DM; Derzi M; Horsley E; Stavros FL
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):95-103. PubMed ID: 22683289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of thromboelastometry for detecting the safe coagulation threshold in patients taking acenocoumarol after elective heart valve replacement.
    Blasi A; Muñoz G; de Soto I; Mellado R; Taura P; Rios J; Balust J; Beltran J
    Thromb Res; 2015 Sep; 136(3):669-72. PubMed ID: 26232350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease.
    Monastero R; Camarda R; Camarda C
    Clin Ther; 2007 Dec; 29(12):2706-9. PubMed ID: 18201587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects.
    Stavros F; Kramer WG; Wilkins MR
    Br J Clin Pharmacol; 2010 Jan; 69(1):23-6. PubMed ID: 20078609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled study of interaction between nabumetone and acenocoumarol.
    Pardo A; García-Losa M; Fernández-Pavón A; del Castillo S; Pascual-García T; García-Méndez E; Dal-Ré R
    Br J Clin Pharmacol; 1999 Apr; 47(4):441-4. PubMed ID: 10233210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
    Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
    Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations.
    Dhaun N; Vachiery JL; Benza RL; Naeije R; Hwang LJ; Liu X; Teal S; Webb DJ
    J Heart Lung Transplant; 2014 May; 33(5):521-7. PubMed ID: 24656288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 17. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.
    Marco F; Gutiérrez JI; Orkolaga K; Márquez JA; Ojínaga MJ; de Zárate IO; de Heredia JM
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):509-12. PubMed ID: 16905959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Boddi V; Gensini GF; Abbate R; Prisco D
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):269-75. PubMed ID: 12695750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitaxentan: in pulmonary arterial hypertension.
    Scott LJ
    Drugs; 2007; 67(5):761-70; discussion 771-2. PubMed ID: 17385944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.